Prediction Model of Colorectal Adenoma Recurrence-Carcinogenesis Risk With TCM-WM Multimodal Feature Fusion

Recruiting Observational Study
Colorectal Cancer Control and Prevention
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
Beijing Friendship Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This project focuses on developing a risk prediction model for the recurrence and malignant transformation of colorectal adenomas by integrating multimodal features from both Traditional Chinese Medicine (TCM) and Western medicine. Led by Dr. Wei Hongtao from Beijing Friendship Hospital, Capital Medical University, the primary objective is to mine clinical characteristics from both medical systems…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Meet the diagnostic criteria for colorectal adenoma (Western medicine) and the relevant TCM syndromes. * Aged 18 years or older. * Willing to undergo regular follow-up examinations (including colonoscopy and laboratory tests) and sign the informed consent form. Exclusion Crit…
Contacts

Hongtao Wei

+86 13811216906

gulvzhe@126.com

CONTACT